{"data":{"id":"CAP-U-037922","name":"FCA Health Innovations III AI, LP","firm_id":"CAP-F-001280","firm_link_confidence":"low","sec_cik":"0002133480","vintage_year":2026,"redirect_to":null,"source_id":"CAP-S-000021","confidence":"high","reviewed_by":"sonnet","created_at":"2026-08-30","updated_at":"2026-08-30","external_ids":{"sec_cik":"0002133480"},"field_sources":{},"aliases":[],"filings":[{"accession_no":"0002133480-26-000001","fund_id":"CAP-U-037922","filed_at":"2026-05-15","form_type":"D","total_offering_amount":175000000,"total_amount_sold":3100000,"total_remaining":171900000,"investor_count":22,"minimum_investment":100000,"exemptions":["06b","3C","3C.1"],"related_persons":[{"name":"Andrew J. Bouldin","role":"Executive Officer"},{"name":"Matthew A. King","role":"Executive Officer"},{"name":"A. FCA Health Innovations III SLP, LLC","role":"Executive Officer"},{"name":"A. FCA Health Innovations III GP, LLC","role":"Executive Officer"},{"name":"Whitney H. Kalb","role":"Executive Officer"},{"name":"Charles W. Johnson","role":"Executive Officer"}],"source_id":"CAP-S-000021"}],"source":{"id":"CAP-S-000021","kind":"sec_formd","url":"https://www.sec.gov/files/datastandardsinnovation/data/form-d-data-sets/2026q2_d.zip","fetched_at":"2026-08-30T18:59:59Z","r2_key":"formd/datasets/2026q2_d.zip","hash":"sha256:e7a08365a5600d1e72357687c76cda20075c00e6817008fcd9fa7064a984592a","title":"SEC Form D data set 2026Q2","created_at":"2026-08-30"}},"redirected_from":null,"publisher":"キャピタリスト編集部","license":"CC BY 4.0","site":"https://capitalist.work"}